Biotech Stock News (KBIO) (SNY) (CLVS) (AZN) (VRTX)

KaloBios Pharmaceuticals (NASDAQ:KBIO) Last week I wrote how Kalobios was winding down its operations and was looking to put itself up for sale. In an unforeseen event, Martin Shkreli took a big investment in the company sending the share price higher. Before I go any further let me provide a little backstory so that everyone … Read more